Stayble Therapeutics
Sara Richardson has a long and broad background in the pharmaceutical and medical device industry, with 13 years of experience from clinical drug product development at AstraZeneca, where she has held various science and leader roles in projects spanning from candidate nomination to Ph3 clinical studies. Sara holds a PhD in Analytical Chemistry from Lund University.
Stayble Therapeutics
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.